임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2/3상모집 중· Follicular LymphomaA Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
리드: 머크(MSD)
- 2/3상모집 중· Non Small Cell Lung Cancer (Squamous or Non Squamous)A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
협력: 머크(MSD)
- 2/3상모집 중· Idiopathic HypersomniaA Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
리드: 다케다
- 2/3상모집 중· B-cell Acute Lymphoblastic LeukemiaA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
리드: 머크(MSD)
- 2/3상모집 중· Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal AdenocarcinomaSymbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
리드: 화이자
- 2/3상모집 중· Metastatic Pancreatic Ductal AdenocarcinomaA Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
리드: 애브비
- 2/3상모집 중· Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
리드: BMS · 협력: 바이오엔테크
- 2/3상모집 중· Kidney Transplant RejectionA Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
리드: 사노피
- 2/3상모집 중· Moderate to Severe Chronic Obstructive Pulmonary DiseaseA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
리드: 화이자
- 2/3상모집 중· Multiple MyelomaA Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
리드: 애브비
- 2/3상모집 중· Metastatic Non-small Cell Lung Cancer With MTAP DeletionA Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
리드: BMS
- 2/3상모집 중· Untreated, Unresectable, or Metastatic Colorectal CancerA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
리드: BMS · 협력: 바이오엔테크
- 2/3상모집 중· Human Immunodeficiency Virus Type 1 (HIV-1) InfectionA Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
리드: 머크(MSD)
- 2/3상모집 중· Non-Small Cell Lung CancerA Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
리드: 애브비
- 2/3상모집 중· Haematological MalignancyDETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
협력: 로슈
- 2/3상모집 중· Hepatocellular CarcinomaDurvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma
협력: 아스트라제네카
- 2/3상모집 중· Crohn DiseaseA Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
리드: 얀센(J&J)
- 2/3상모집 중· Membranous Nephropathy - PLA2R InducedObinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study
협력: 로슈
- 2/3상모집 중· Primary Membranous NephropathyEvaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
리드: 버텍스
- 2/3상모집 중· Heterozygous Familial Hypercholesterolemia (HeFH)A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
리드: 머크(MSD)
- 2/3상모집 중· Non-Squamous Non-Small Cell Lung CancerA Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
리드: 애브비
- 2/3상모집 중· Advanced MelanomaSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
협력: 머크(MSD)
- 2/3상모집 중· Non-small Cell Lung CancerSafety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
리드: 바이오엔테크 · 협력: BMS
- 2/3상모집 중· Alzheimers DiseaseA Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
협력: 일라이 릴리
- 2/3상모집 중· Alzheimers DiseaseA Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
협력: 일라이 릴리
- 2/3상모집 중· Solid TumourDETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
협력: 노바티스
- 2/3상모집 중· B-cell Non Hodgkin LymphomaA Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
협력: 리제네론
- 2/3상모집 중· Non-Small Cell Lung CancerStudy to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
리드: 애브비
- 2/3상모집 중· Haematological MalignancyDETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
협력: 로슈
- 2/3상모집 중· Lymphatic MalformationsAlpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
리드: 노바티스
- 2/3상모집 중· Systemic Sclerosis Associated Interstitial Lung DiseaseA Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
리드: GSK
- 2/3상모집 중· Narcolepsy Type 1A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
리드: 다케다
- 2/3상모집 중· Haematological MalignancyDETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
협력: 로슈
- 2/3상모집 중· Polyradiculoneuropathy, Chronic Inflammatory DemyelinatingEfficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
리드: 얀센(J&J)
- 2/3상모집 중· Myasthenia GravisA Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
리드: 얀센(J&J)
- 2/3상모집 중· Colitis, UlcerativeA Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
리드: BMS
- 2/3상모집 중· Proteinuric Kidney DiseasePhase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
리드: 버텍스
- 2/3상모집 중· Endometrial CancerRefining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
협력: 아스트라제네카
- 2/3상모집 중· Unresectable Head and Neck Squamous Cell CarcinomaA Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
리드: 바이오엔테크
- 2/3상모집 중· GlioblastomaA Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
협력: 아스트라제네카
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.